Patient perspectives on epidermal growth factor receptor inhibitor-induced skin toxicities: a qualitative study

Clinical staff should prioritize attention to the physical and psychological distress experienced by patients with cancer with EGFRI-induced skin toxicities. Implementing enhanced symptom evaluation and management, providing tailored psychological support, and offering professional guidance can help patients effectively cope with their symptoms and foster their self-growth.